Global

Neurology Experts

Anna Falk


Neuroscience
The European Neuroscience Institute at Karolinska Institutet, Stockholm
Greece

Biography

We are interested in how the correct size and organization of the human brain is established and the role of proper neural stem cell regulation in the process. Studies of human brain development in health and disease have until recently been close to impossible due to lack of relevant tissue to study. We use reprogramming, iPS cells and neural differentiation as tools to derive the relevant cells to study. We are currently studying neurodevelopmental disorders like, Down Syndrome, ASD, monogenetic intellectual disabilities in addition to Alzheimer’s disease. We reprogram patient cells to iPS cells, which we use to derive neural stem cells and neurons for our in vitro studies. We compare patient and control neural stem cells and neurons in processes like proliferation, differentiation, migration, apoptosis, and functionality of neurons. We have detected diseases phenotypes in patient specific neural stem cells and/or neurons of the diseases we thus far have studied. For example, neural stem cells of Down syndrome patients proliferate slower then neural stem cells from healthy people. We are currently studying the molecular background of the slow expansion of the neural progenitor cells.

Research Interest

Neuroscience

Publications

  • Tailor J., Kittappa R., Leto K., Gates M., Borel M., Paulsen O., Spitzer S., Karadottir RT., Rossi F., Falk A., Smith A. (2013) Stem cells expanded from the human embryonic hindbrain stably retain regional specification and high neurogenic potency. J. Neurosci., 33(30) : 12407-22.

  • Zhang D, Pekkanen-Mattila M, Shahsavani M, Falk A, Teixeira AI, Herland A. A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons. Biomaterials. 2013 Nov 27. doi:pii: S0142-9612(13)01381-1. 10.1016

  • Wu S, Johansson J, Damdimopoulou P, Shahsavani M, Falk A, Hovatta O, Rising A. Spider silk for xeno-free long-term self-renewal and differentiation of human pluripotent stem cells. Biomaterials. 2014 Oct;35(30):8496-502 PMID: 25043502

Global Experts from Greece

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America